Company / Operating Cash Flow per Share
ENDONOVO THERAPEUTICS, INC. Operating Cash Flow per Share History
FY2014-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.01
FY2022
5-year range
-$5.89 / -$0.01
FY2018-FY2022
Trend
+77.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-5.89 in FY2019 to $-0.01 in FY2022.
Based on SEC 10-K filings.
-0.01 in FY2022.
Improved from $-0.62 to $-0.01 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENDONOVO THERAPEUTICS, INC.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2022, operating cash flow per share increased 77.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$0.01 | +77.3% |
| FY2021 | -$0.04 | +93.6% |
| FY2020 | -$0.62 | +89.4% |
| FY2019 | -$5.89 | -64799.5% |
| FY2018 | -$0.01 | +61.3% |
| FY2016 | -$0.02 | -87.7% |
| FY2015 | -$0.01 | +98.9% |
| FY2014 | -$1.09 | - |
| FY2011 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026